维普期刊资源整合服务平台（V6.5）

71篇 您的检索式：作者名="Ferrajoli"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia显示文摘	Estey E Garcia-Manero G Ferrajoli A	2006	Blood2006，107，34：	1
2	Prognostic value ofmiR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia 显示文摘	Ferrajoli A Shanafelt TD Ivan C	2013	Blood2013，122，11：	1
3	High levels ofvascular endothelial growth factor receptor- 2 correlate with shortenedsurvival in chronic lymphocytic leukemia显示文摘	Ferrajoli A Manshouri T Estrov Z	2001	Clin Cancer Res2001，7，4：	1
4	Treatment of younger patients with chronic lymphocyticleukemia 显示文摘	Ferrajoli A	2010	Hematology Am Soc Hematol Educ Program2010，8289，：	1
5	Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia显示文摘	Ferrajoli A Lee BN Schlette EJ	2008	Blood2008，111，：	1
6	Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia显示文摘	Ferrajoli A Shanafelt TD Ivan C	2013	Blood2013，，11：	1
7	High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia 显示文摘	Manshouri T Estrov Z	2001	Clin Cancer Res2001，7，4：	1
8	Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia显示文摘	Estey E Garcia-Manero G Ferrajoli A	2006	Blood2006，107，9：	1
9	High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chroic lymphocytic leukemia显示文摘	Manshouri T Estrov Z	2001	Clin Cancer Res2001，7，4：	1
10	High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia显示文摘	Ferrajoli A Manshouri T Estrov Z	2001	Clin Cancer Res2001，7，4：	1
11	The clinical significance of tumor necrosis factor - α plasma level in patients having chronic lymphocytic leukemia 显示文摘	Ferrajoli A Keating M J Manshouri T	2002	Blood2002，100，4：	1
12	Activity of alemtuzumab in patients with CD52-positive acute leukemia 显示文摘	Tibes R Keating M J Ferrajoli A	2006	Cancer2006，106，12：	1
13	Use of alltrans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia显示文摘	Richard S Garcia-Manero G Ferrajoli A	2006	Blood2006，107，10：	1
14	High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia显示文摘	Ferrajoli A Manshouri T Estrov Z	2001	Clin Cancer Res2001，7，4：	1
15	High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia 显示文摘	Ferrajoli A Manshouri T Estrov Z	2001	Clin Cancer Res2001，7，4：	1
16	Use of all-trans retinoieacid plus arsenic trioxide as an alternative to chemotherapy in un- treated acute promyelocytic leukemia 显示文摘	Estey E Garcia-Manero G Ferrajoli A	2006	Blood2006，107，9：	1
17	Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia 显示文摘	ESTEY E GARCIA-MANERO G FERRAJOLI A	2006	Blood2006，107，：	1
18	Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia 显示文摘	Ferrajoli A Lee BN Schlette E J	2008	Blood2008，111，11：	1
19	The JAK-STATpathway : a therapeutic target in hematological malignancies显示文摘	Ferrajoli A Faderl S Ravandi F	2006	Curr Cancer Drug Targets2006，6，8：	1
20	Lenalidomide inducescomplete and partial remissions in patients w ith replapsed and refractory chronic lymphocytic leukemia显示文摘	Ferrajoli A Lee BN Schlete EJ	2008	Blood2008，111，11：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示